BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18337626)

  • 1. Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.
    Awar O; Duvic M
    Oncology; 2007; 73(1-2):130-5. PubMed ID: 18337626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous mycosis fungoides responsive to gemcitabine.
    Fargnoli MC; Peris K; Francesconi F; Cantonetti M; Cerroni L; Chimenti S
    Eur J Dermatol; 2002; 12(5):479-81. PubMed ID: 12370140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
    Masuzawa M; Takasu H; Amoh Y
    Gan To Kagaku Ryoho; 2015 Dec; 42(13):2451-5. PubMed ID: 26809303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose gemcitabine efficacious in three patients with tumor-stage mycosis fungoides.
    Buhl T; Bertsch HP; Kaune KM; Mitteldorf C; Schön MP; Kretschmer L
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):E21-4. PubMed ID: 19858049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of the combination of systemic gemcitabine and intralesional brentuximab vedotin in tumor-stage mycosis fungoides.
    Torre-Castro J; Recio-Monescillo M; Castillo Bazan E; Díaz de la Pinta J; Rodríguez Pinilla M; Requena L; Córdoba R
    Int J Dermatol; 2024 Jun; 63(6):828-830. PubMed ID: 38419393
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab.
    Weder P; Anliker M; Itin P; Bargetzi M
    Dermatology; 2004; 208(3):281-3. PubMed ID: 15118391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of combination therapies for mycosis fungoides.
    Humme D; Nast A; Erdmann R; Vandersee S; Beyer M
    Cancer Treat Rev; 2014 Sep; 40(8):927-33. PubMed ID: 24997678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
    Zinzani PL; Magagnoli M; Bendandi M; Orcioni GF; Gherlinzoni F; Albertini P; Pileri SA; Tura S
    Ann Oncol; 1998 Dec; 9(12):1351-3. PubMed ID: 9932168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic alveolar condensations with erythematous cutaneous lesions].
    Darmon A; Carlos Molano L; Abramovici O; Duval-Modeste AB; Louvel JP; Piton N; Muir JF; Cuvelier A
    Rev Mal Respir; 2016 Sep; 33(7):634-8. PubMed ID: 26827103
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
    Zinzani PL; Baliva G; Magagnoli M; Bendandi M; Modugno G; Gherlinzoni F; Orcioni GF; Ascani S; Simoni R; Pileri SA; Tura S
    J Clin Oncol; 2000 Jul; 18(13):2603-6. PubMed ID: 10893292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy.
    Siriphukpong S; Pattanaprichakul P; Sitthinamsuwan P; Karoopongse E
    J Med Assoc Thai; 2010 Nov; 93(11):1321-6. PubMed ID: 21114213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides stage IB progressing to cutaneous tumors.
    Berger E; Altiner A; Chu J; Patel R; Sanders S; Latkowski JA
    Dermatol Online J; 2011 Oct; 17(10):5. PubMed ID: 22031631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.
    MacArthur KM; Jariwala N; Kim EJ; Rook AH
    Acta Derm Venereol; 2017 Mar; 97(3):373-374. PubMed ID: 27868149
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
    Duvic M; Talpur R; Wen S; Kurzrock R; David CL; Apisarnthanarax N
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):51-8. PubMed ID: 16879770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomatoid papulosis terminating as cutaneous T cell lymphoma (mycosis fungoides).
    Madison JF; O'Keefe TE; Meier FA; Clendenning WE
    J Am Acad Dermatol; 1983 Nov; 9(5):743-7. PubMed ID: 6643771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
    Schappell DL; Alper JC; McDonald CJ
    Arch Dermatol; 1995 Mar; 131(3):307-13. PubMed ID: 7887660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients.
    Zackheim HS; Kashani-Sabet M; McMillan A
    J Am Acad Dermatol; 2003 Nov; 49(5):873-8. PubMed ID: 14576667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
    Heisig M; Maj J; Szepietowski JC; Reich A
    Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follicular mycosis fungoides (FMF): a rare disease].
    Zipprich F; Bräuninger W; Knop J; Enk A
    Hautarzt; 2001 Mar; 52(3):240-3. PubMed ID: 11284071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.